Upload Avatar (500 x 500)
Ke Gong
Basic Medical Sciences
Wuhan University
Hubei
Language: Chinese, English
Egfr
Rtk
Cancer Genomics
Drug Resistance
Immunotherapy
Precision Medicine
Clinical Trials
Tumor Microenvironment
Signal Transduction
Molecular Biology
Areas of Focus
- Tumor cell signaling and targeted molecular mechanisms of resistance in immunotherapy
- Database and precision therapy for cancer treatment
Work Experience
- 2014-2015 Postdoctoral Researcher, Emory University, USA
- 2015-2019 Postdoctoral Researcher, University of Texas Southwestern Medical Center, USA
- 2019-2021 Lecturer, University of Texas Southwestern Medical Center, USA
- 2021-2022 Distinguished Researcher, Wuhan University
- 2022-present Professor, Wuhan University
- 2024-present Principal Investigator, Wuhan University
Academic Background & Achievements
- 2003-2007 Bachelor in Biology, Wuhan University
- 2008-2014 PhD in Cell Biology, Wuhan University
Publications
- Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids, Ke Gong, Gao Guo, Nicole A. Beckley, Xiaoyao Yang, Yue Zhang, David E. Gerber, John D. Minna, Sandeep Burma, Dawen Zhao, Esra A. Akbay & Amyn A. Habib, 2021
- EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer, Ke Gong, Gao Guo, Nishah Panchani, Matthew E. Bender, David E. Gerber, John D. Minna, Farjana Fattah, Boning Gao, Michael Peyton, Kemp Kernstine, Bipasha Mukherjee, Sandeep Burma, Cheng-Ming Chiang, Shanrong Zhang, Adwait Amod Sathe, Chao Xing, Kathryn H. Dao, Dawen Zhao, Esra A. Akbay, and Amyn A. Habib, 2020
Awards
- 2021 Wuhan University Talent Introduction Project
- 2021 Wuhan 'Wuhan Talent' Outstanding Youth Talent Project
- 2021 Hubei Province Key Contact Expert
- 2022 National Talent Project (Execution period: 2023-2025)
- 2023 National Natural Science Foundation of China (Execution period: 2024-2027)
